TNGX R&D Expenses
Tango Therapeutics Inc · R&D Expenses
TNGX R&D Expenses
Latest reported$134.37Mperiod ending
TNGX R&D Expenses ($32.27M → $134.37M)
Annual R&D Expenses
High-resolution chart · PNG
TNGX r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 132,165,000 | |
| 143,918,000 | |
| 115,198,000 | |
| 105,906,000 | |
| 77,636,000 | |
| 49,991,000 | |
| 32,274,000 |